NTLA · Intellia Therapeutics, Inc. · Share Buybacks
$9.70
-0.85 (-8.06%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$1.36B
Shares
140.36M
Volume · Nov 13
11.42M
Avg daily vol (3M)
4.57M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Key facts
CIK
1652130
CUSIP
45826J105
13F (30d)
249 filings
229 filers
Visit website
Investor relations